Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Haematologica
Prif Awduron: Costacurta, Matteo, Vervoort, Stephin J, Hogg, Simon J, Martin, Benjamin P, Johnstone, Ricky W, Shortt, Jake
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Fondazione Ferrata Storti 2020
Pynciau:
Letters to the Editor
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252923/
https://ncbi.nlm.nih.gov/pubmed/33375771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2020.265611
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg